These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21376492)

  • 21. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
    Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
    Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted MRI in cervical lymph nodes: differentiation between benign and malignant lesions.
    Perrone A; Guerrisi P; Izzo L; D'Angeli I; Sassi S; Mele LL; Marini M; Mazza D; Marini M
    Eur J Radiol; 2011 Feb; 77(2):281-6. PubMed ID: 19716671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal spread in the neck: MRI detection on the basis of pixel-based time-signal intensity curve analysis.
    Sumi M; Nakamura T
    J Magn Reson Imaging; 2011 Apr; 33(4):830-8. PubMed ID: 21448947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions.
    Matsuzaki H; Hara M; Yanagi Y; Asaumi J; Katase N; Unetsubo T; Hisatomi M; Konouchi H; Takenobu T; Nagatsuka H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jan; 113(1):126-33. PubMed ID: 22669071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach.
    Cheng HL
    J Magn Reson Imaging; 2009 Oct; 30(4):864-72. PubMed ID: 19787732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
    King AD; Chow SK; Yu KH; Mo FK; Yeung DK; Yuan J; Law BK; Bhatia KS; Vlantis AC; Ahuja AT
    PLoS One; 2015; 10(12):e0144770. PubMed ID: 26657972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram.
    Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ
    Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
    Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
    Kim S; Quon H; Loevner LA; Rosen MA; Dougherty L; Kilger AM; Glickson JD; Poptani H
    J Magn Reson Imaging; 2007 Dec; 26(6):1607-17. PubMed ID: 17968962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
    Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
    J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histogram analysis of apparent diffusion coefficient maps for the differentiation between lymphoma and metastatic lymph nodes of squamous cell carcinoma in head and neck region.
    Wang YJ; Xu XQ; Hu H; Su GY; Shen J; Shi HB; Wu FY
    Acta Radiol; 2018 Jun; 59(6):672-680. PubMed ID: 28870086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.